Search Results 251-260 of 14932 for Meclizine

  1. High-dose Prophylactic Gabapentin (HOPE) Vs. Placebo To Prevent Opioid Use For Oral Mucositis Pain During Concurrent Chemoradiation For Head And Neck Cancer - Mayo Clinic

    About this study. This phase III trial tests if gabapentin can prevent the need for opiate pain medication for mouth sores (oral mucositis) in patients ...

  2. Medical and Resource Facilitation Intervention After Traumatic Brain Injury (MRFI) - Mayo Clinic

    The purpose of this study is to determine if there are changes in mild traumatic brain injury (mTBI) and/or repetitive head impacts (RHI) detectible with ...

  3. Publications - Krystal M. Renszel, D.O. - Mayo Clinic

    Geyer H, Renszel K, Kirkilas G, Johnson C, Moffit R, Kurtenbach M. A State Blueprint to Equip Schools With a Uniform Overdose Response Strategy. Pediatrics.

  4. A Study of LY2875358 in Non Small Cell Lung Cancer (NSCLC) Participants - Mayo Clinic

    About this study. The primary purpose of this study is to evaluate the efficacy of the study drug known as LY2875358, administered alone or in combination ...

  5. Chlordiazepoxide and clidinium (oral route) - Side effects & dosage - Mayo Clinic

    Chlordiazepoxide and clidinium combination is used in combination with other medicines to treat stomach or bowel problems including peptic ulcers, irritable ...

  6. Phase 1 Dose Finding Study of Belinostat for Treatment of Patients With Peripheral T-cell Lymphoma (PTCL) - Mayo Clinic

    The primary objective of this study is to determine the Maximum Tolerated Dose (MTD) for belinostat when combined with CHOP regimen and establish the ...

  7. A Study of MPDL3280A (Anti-PD-L1 Antibody) Combined with Carboplatin and Paclitaxel , and with or without Bevacizumab, for Patients who have Stage IV Non-Squamous Non-Small Cell Lung Cancer - Mayo Clinic

    A Study of MPDL3280A (Anti-PD-L1 Antibody) Combined with Carboplatin and Paclitaxel , and with or without Bevacizumab, for Patients who have Stage IV Non- ...

  8. Ibrutinib and Ixazomib Citrate in Treating Participants With Relapsed or Refractory Waldenstrom Macroglobulinemia - Mayo Clinic

    Enzyme inhibitors, such as ibrutinib and ixazomib citrate, may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth.

  9. Hematology - Clinical trials

    Hematology — Learn about innovative diagnosis and treatment options for blood diseases, including cancers, at Mayo Clinic.

  10. Multiple sclerosis - Doctors and departments - Mayo Clinic

    This nervous system condition causes a range of symptoms. While there's no cure, it's possible to have long periods of remission.